天津科学技术出版社

自体造血干细胞移植治疗成人急性白血病的研究进展

潘攀 1,2,庞爱明 1,2 *,姜尔烈 1,2 *
作者信息
  1. 1 中国医学科学院血液病医院(中国医学科学院血液学研究所),血液与健康全国重点实验室,国家血液系统疾病临床医学研究中心,细胞生态海河实验室,天津 300020
  2. 2 天津医学健康研究院,天津 301600
*通信作者

摘要

自体造血干细胞移植(ASCT)是通过回输患者自身的造血干细胞,重建其造血与免疫功能的一种重要治疗手段。 自 20 世纪 80 年代发展至今,该技术已广泛应用于包括急性白血病(AL)在内的多种血液恶性肿瘤的治疗,显著延长了患者的无病生存期,并使部分患者获得临床治愈;同时,该技术在缩短疗程、降低医疗成本、改善生活质量等方面体现出显著优势。 近年来,随着微小残留病检测、小分子靶向药物及免疫疗法等新型诊疗技术的快速发展,ASCT 的治疗流程持续优化,疗效不断提升。 本文主要围绕 ASCT 治疗成人 AL 患者的研究进展进行综述,重点探讨其适应证的优化、预处理方案的革新以及与新型治疗策略的整合等方面的进展,以期为临床实践提供参考。

Advancements in autologous hematopoietic stem cell transplantation in the treatment of adult acute leukemia

Pan PAN 1,2, Aiming PANG 1,2 *, Erlie JIANG 1,2 *
Author Information
  1. 1 State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College
  2. 2 Tianjin Institute of Health Science,Tianjin 301600, China
*Corresponding author

Abstract

Autologous hematopoietic stem cell transplantation (ASCT) is a critical therapeutic modality that restores hematopoietic and immune functions through the reinfusion of a patient's own hematopoietic stem cells. Since its development in the 1980s, this technique has been widely applied in the treatment of various hematologic malignancies, including acute leukemia (AL). It has significantly prolonged disease-free survival (DFS) and enabled some patients to achieve a clinical cure. Furthermore, ASCT has demonstrated significant advantages in shortening treatment duration, reducing medical costs, and improving quality of life. In recent years, with the rapid advancement of novel diagnostic and therapeutic technologies — such as minimal residual disease (MRD) monitoring, small-molecule targeted agents, and immunotherapy — the ASCT treatment protocol has been continuously optimized, leading to steadily improving clinical efficacy. This article reviews the research progress of ASCT in the treatment of adult patients with AL, focusing on the optimization of indications, innovations in conditioning regimens, and integration with novel therapeutic strategies, with the aim of providing a reference for clinical practice.

再生医学研究 Copyright © 2026. All Rights Reserved